$cldi
Calidi Biotherapeutics ($CLDI) CEO Eric Poma discusses the company's innovative cancer-fighting platforms in an investor spotlight. A recent post highlights a peer-reviewed paper on Ivermectin as cancer immunotherapy, urging readers to review it.
About $cldi
$cldi is a cryptocurrency.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [-----] +194,400%
[--] Month: [------] +215%
[--] Months: [---------] -66%
[--] Year: [---------] -70%
1-Year High: [-------] on 2025-07-09
1-Year Low: [--] on 2026-01-04
Engagements by network (24h): X: [-----]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [-----] on 2025-07-09
1-Year Low: [--] on 2025-10-26
Mentions by network (24h): X: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $cldi in the last [--] hours which is up 46% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [-----] on 2025-07-17
1-Year Low: [--] on 2025-09-16
The most influential creators that mention $cldi in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @RedChip | [--] | [------] | [--] | [-----] |
| @LucyTrader98 | [--] | [---] | [--] | [---] |
| @Rocket_Labs22 | [--] | [---] | [--] | [---] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
| @BullRunz22 | [--] | [---] | [--] | [--] |
| @Signal_Trader01 | [--] | [--] | [--] | [--] |
| @Bigg0698830 | [--] | [--] | [--] | [--] |
| @DhigramP5875 | [--] | [--] | [--] | [--] |
Sentiment: 25%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 25%
Daily Average: 81%
[--] Month: 100% no change
[--] Months: 100% +11%
[--] Year: 100% +14%
1-Year High: 100% on 2025-03-16
1-Year Low: 7% on 2026-01-01
Most Supportive Themes:
- Ivermectin as Cancer Immunotherapy: (100%) A peer-reviewed paper suggests Ivermectin can be used as a cancer immunotherapy, with a call to read it before it's removed.
Most Critical Themes:
Top $cldi Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"🧬 Calidi Biotherapeutics $CLDI: Pioneering a New Frontier in Cancer Treatment @CalidiBio is redefining immuno-oncology with its next-gen stem cell-based delivery platforms for oncolytic virotherapy (OV) a sector projected to reach $15B+ annually in the U.S. Watch our full overview to learn how Calidi is engineering tomorrows oncology breakthroughs: $CLDI $AMGN $JNJ $CADL $BMRN $CPRX $CGON $REPL $NBTX $IBRX https://bit.ly/4l96d9w https://bit.ly/4l96d9w"
X Link @RedChip 2026-02-17T13:55Z [----] followers, [---] engagements
"📊 This week: [--] biotech catalysts 📅 Feb [--] - Feb [--] 🎯 [--] FDA decision 🔬 [--] trial readouts 🎯 Tue: $ALDX FDA PDUFA Date reproxalap (standard) 🔬 Tue: $OCUL Phase [--] Results - SOL-1 📌 Tue: $SNY Other 📌 Tue: $NVO Regulatory Decision - Wegovy 🎤 Wed: $CLDI Conference Presentation - RedTail platform Get free alerts #biotech #PDUFA #clinicaltrials #FDA http://catalystalert.io/this-week http://catalystalert.io/this-week"
X Link @catalystalert 2026-02-16T13:00Z [---] followers, [----] engagements
"🎙 Investor Spotlight: Why Calidi Biotherapeutics $CLDI Is a Company to Watch Eric Poma PhD CEO of @CalidiBio breaks down the companys innovative approach to fighting cancer using proprietary stem cell-based platforms to deliver powerful oncolytic viruses. Why It Matters for Investors: Massive Market Opportunity: Addressing a $13B$15B U.S. market across high-grade gliomas metastatic melanoma TNBC and more. Breakthrough Platforms: Three-tiered pipeline (NeuroNova SuperNova RTNova) tackling both localized and metastatic cancers. Clinical Progress: IND cleared for Phase 1b/2 trial in high-grade"
X Link @RedChip 2026-02-12T13:55Z [----] followers, 43.3K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing